NCT04177342

Brief Summary

Peroral endoscopic myotomy (POEM) is a minimally invasive treatment for esophageal achalasia with a natural orifice transluminal endoscopic procedure and far less invasive than the standard surgical or laparoscopic Heller myotomy (LHM). Less is known about the postoperative pain after POEM and the minor surgery trauma, short length of stay may lead to underestimation of postoperative pain control. We tend to observe the pain status after the POEM surgery under the empirical treatment in our center, and find a proper intra-operative way of pain control to solve the post-operative pain and seek the possible influence factors of postoperative pain.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
196

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

November 26, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

November 26, 2019

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

April 2, 2019

Last Update Submit

November 22, 2019

Conditions

Keywords

achalasiaPeroral endoscopic myotomypost-operative pain

Outcome Measures

Primary Outcomes (3)

  • post-operative pain condition

    use Visual Analogue Scale/Score(0-10) to record post operative pain

    36 hours after the POEM surgery

  • post-operative PCA usage volumn

    record PCA usage volumn(ml) to see the dosage of opiods used after the surgery

    36 hours after the POEM surgery

  • post-operative sleep quality

    Postoperative sleep quality was investigated with a self-reported sleep questionnaire including 6 yes/no questions(0-6) with full score 6 represented the worst sleep

    48 hoursafter the surgery

Secondary Outcomes (1)

  • chronic pain condition

    28 days after discharge

Study Arms (2)

fentanyl

ACTIVE COMPARATOR

the patients use remifentanil and fentanyl as intra-operatively pain control and compare the post-operative pain condition with the oxycodone group

Drug: Fentanyl

oxycodone

EXPERIMENTAL

the patients use oxycodone and remifentanil as intra-operatively pain control and compare the post-operative pain condition with the fentanyl group

Drug: Oxycodone

Interventions

the patients use remifentanil and fentanyl as intra-operatively pain control and compare the post-operative pain condition with the oxycodone group

fentanyl

the patients use oxycodone and remifentanil as intra-operatively pain control and compare the post-operative pain condition with the fentanyl group

oxycodone

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Achalasia patients undergoing elective POEM surgery
  • age 18-80
  • BMI 18-30 kg/m2

You may not qualify if:

  • Patient refusal
  • ASA≥ 3
  • abnormality of liver and kidney function in patients
  • patients with mental disorder, language disorder, and other patients who can not cooperate with and complete the follow-up and questionnaire pre- and post- operatively
  • patients (including propanotamo, propofol, lidocaine, and other drugs) against drug taboos in the anesthetic scheme
  • patients with chronic pain before operation with analgesic drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Esophageal AchalasiaPain, Postoperative

Interventions

FentanylOxycodone

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCodeineMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Wannan Chen, MD

    Shanhai Zhongshan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: patients will be devided randomly into two groups. One group will be given oxycodone and the other will be given fentanyl during the POEM procedure. Post procedure pain condition will be recorded.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 2, 2019

First Posted

November 26, 2019

Study Start

January 1, 2020

Primary Completion

December 31, 2020

Study Completion

June 30, 2021

Last Updated

November 26, 2019

Record last verified: 2019-11